2009 Annual Meeting | Dementia Update

Date Monday 04/27/09

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Neill R. Graff-Radford, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the differential diagnosis of dementia; recognize the clinical features and practical approaches of the different dementias; understand the basis for amyloid as a therapeutic target in Alzheimer's disease, the molecular basis of different dementias; and the genetic components of the dementias.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
09:00 AM - 09:40 AM		Mild Cognitive Impairment to Alzheimer's Disease Ronald C. Petersen, MD, PhD, FAAN
09:40 AM - 10:20 AM		The Biology of Alzheimer's Disease David M. Holtzman, MD, FAAN
10:30 AM - 10:40 PM		Questions and Answers
10:40 AM - 10:50 AM		Break
10:50 AM - 11:30 AM		Frontotemporal Dementia Bruce L. Miller, MD, FAAN
11:30 AM - 12:10 PM		Subcortical Vascular Dementia Helena C. Chui, MD
12:10 PM - 12:20 PM		Questions and Answers
12:20 PM - 01:40 PM		Lunch
01:40 PM - 02:20 PM		Parkinson-Related Dementias Bradley F. Boeve, MD, FAAN
02:20 PM - 03:00 PM		Normal Pressure Hydrocephalus Neill R. Graff-Radford, MD, FAAN
03:00 PM - 03:10 PM		Questions and Answers
03:10 PM - 03:20 PM		Break
03:20 PM - 04:00 PM		Acute and Subacute Dementias Michael D. Geschwind, MD, PhD, FAAN
04:00 PM - 04:40 PM		Pathology of Dementia Dennis W. Dickson, MD
04:40 PM - 04:50 PM		Questions and Answers

Faculty Disclosures
Helena C. Chui, MD	The institution of Dr. Chui has received research support from National Institute on Aging .
Neill R. Graff-Radford, MD, FAAN	The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
David M. Holtzman, MD, FAAN	No disclosure on file
Dennis W. Dickson, MD	Dr. Dickson has nothing to disclose.
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Michael D. Geschwind, MD, PhD, FAAN	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..

��ɫ��

��ɫ��